Helmholtz Centre for Infection Research

8 articles about Helmholtz Centre for Infection Research

• Evotec And Helmholtz Centre Joining Platforms And Forces For Novel Antibiotics

  2/20/2019

  Evotec and helmholtz aim to jointly develop cystobactamid derivatives into a new class of broad spectrum antiobiotics targeting high-priority pathogens

• 

  Broad Institute Fends off CRISPR Patent Lawsuit, at Least for Now

  9/11/2018

  It was a win for the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, as a federal court of appeals ruled against the University of California (UC) on CRISPR patents.

• Ascenion’s Portfolio Company VPM Acquired by SII

  8/21/2018

  Ascenion GmbH, the technology transfer partner of the Helmholtz Institute for Infection Research (HZI), has successfully negotiated the trade sale of the HZI spin-off Vakzine Projekt Management GmbH (VPM) to its longstanding partner, Serum Institute of India Pvt. Ltd (SII), in an all-cash deal.

• Lead Discovery Center And Helmholtz Centre for Infection Research Enter Partnership For The Discovery Of New Drugs Against Multi-Resistant Bacteria

  3/31/2015

• New Pathway to Cheap Insulin, Helmholtz Centre for Infection Research Study

  6/1/2010

• Immune System's Guard Against Cancer: How Immuno-Messenger Substances Can Inhibit Tumour Growth, Helmholtz Centre for Infection Research Study

  4/7/2010

• Researchers Develop Key Brake For Immune Cells In Petri Dish; Hope For Easier Organ Transplantation?, Helmholtz Centre for Infection Research And Medical School Hannover Study

  6/18/2009

• Argyrin: Natural Substance Raises Hope for New Cancer Therapies in Helmholtz Centre for Infection Research, Hannover Medical School and Leibniz-Universität Study

  7/9/2008